Inhibition of the IKK/NF-[kappa]B pathway by AAV gene transfer improves muscle regeneration in older mdx mice

The I[kappa]B kinase (IKK[alpha], [beta] and the regulatory subunit IKK[gamma]) complex regulates nuclear factor of [kappa]B (NF-[kappa]B) transcriptional activity, which is upregulated in many chronic inflammatory diseases. NF-[kappa]B signaling promotes inflammation and limits muscle regeneration...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gene therapy 2010-12, Vol.17 (12), p.1476
Hauptverfasser: Tang, Y, Reay, D P, Salay, M N, Mi, M Y, Clemens, P R, Guttridge, D C, Robbins, P D, Huard, J, Wang, B
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page 1476
container_title Gene therapy
container_volume 17
creator Tang, Y
Reay, D P
Salay, M N
Mi, M Y
Clemens, P R
Guttridge, D C
Robbins, P D
Huard, J
Wang, B
description The I[kappa]B kinase (IKK[alpha], [beta] and the regulatory subunit IKK[gamma]) complex regulates nuclear factor of [kappa]B (NF-[kappa]B) transcriptional activity, which is upregulated in many chronic inflammatory diseases. NF-[kappa]B signaling promotes inflammation and limits muscle regeneration in Duchenne muscular dystrophy (DMD), resulting in fibrotic and fatty tissue replacement of muscle that exacerbates the wasting process in dystrophic muscles. Here, we examined whether dominant-negative forms of IKK[alpha] (IKK[alpha]-dn) and IKK[beta] (IKK[beta]-dn) delivered by adeno-associated viral (AAV) vectors to the gastrocnemius (GAS) and tibialis anterior (TA) muscles of 1, 2 and 11-month-old mdx mice, a murine DMD model, block NF-[kappa]B activation and increase muscle regeneration. At 1 month post-treatment, the levels of nuclear NF-[kappa]B in locally treated muscle were decreased by gene transfer with either AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn, but not by IKK wild-type controls (IKK[alpha] and [beta]) or phosphate-buffered saline (PBS). Although treatment with AAV-IKK[alpha]-dn or AAV-IKK[beta]-dn vectors had no significant effect on muscle regeneration in young mdx mice treated at 1 and 2 months of age and collected 1 month later, treatment of old (11 months) mdx with AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn significantly increased levels of muscle regeneration. In addition, there was a significant decrease in myofiber necrosis in the AAV-IKK[alpha]-dn- and AAV-IKK[beta]-dn-treated mdx muscle in both young and old mice. These results demonstrate that inhibition of IKK[alpha] or IKK[beta] in dystrophic muscle reduces the adverse effects of NF-[kappa]B signaling, resulting in a therapeutic effect. Moreover, these results clearly demonstrate the therapeutic benefits of inhibiting NF-[kappa]B activation by AAV gene transfer in dystrophic muscle to promote regeneration, particularly in older mdx mice, and block necrosis. [PUBLICATION ABSTRACT]
doi_str_mv 10.1038/gt.2010.110
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_816560851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2207886421</sourcerecordid><originalsourceid>FETCH-LOGICAL-p97t-7234438874a529dd80848c695517761c144de8bd0757040fdd355a7549b2b3b73</originalsourceid><addsrcrecordid>eNotjk1PwkAYhDdGExE9-Qc23gvvfm-PSAQbiF6IF2PItruFYr_sblX-vUU9TSYzeWYQuiUwIcD0dBcmFE6GwBkaEa5kJLik52gEsYwjRai-RFfeHwCAK01HqErqfZEWoWhq3OQ47B1OVqvp0yJ6fTdta97ucWvC_ssccXrEs9kL3rna4dCZ2ueuw0XVds2n87jqfVY63LlT3plfYDEwSzu0KvuNqyJz1-giN6V3N_86RpvFw2b-GK2fl8l8to7aWIVIUcY501pxI2hsrQbNdSZjIYhSkmSEc-t0akEJBRxya5kQRgkepzRlqWJjdPeHHb599M6H7aHpu3pY3GoihQQtCPsB5gFYLA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>816560851</pqid></control><display><type>article</type><title>Inhibition of the IKK/NF-[kappa]B pathway by AAV gene transfer improves muscle regeneration in older mdx mice</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Tang, Y ; Reay, D P ; Salay, M N ; Mi, M Y ; Clemens, P R ; Guttridge, D C ; Robbins, P D ; Huard, J ; Wang, B</creator><creatorcontrib>Tang, Y ; Reay, D P ; Salay, M N ; Mi, M Y ; Clemens, P R ; Guttridge, D C ; Robbins, P D ; Huard, J ; Wang, B</creatorcontrib><description>The I[kappa]B kinase (IKK[alpha], [beta] and the regulatory subunit IKK[gamma]) complex regulates nuclear factor of [kappa]B (NF-[kappa]B) transcriptional activity, which is upregulated in many chronic inflammatory diseases. NF-[kappa]B signaling promotes inflammation and limits muscle regeneration in Duchenne muscular dystrophy (DMD), resulting in fibrotic and fatty tissue replacement of muscle that exacerbates the wasting process in dystrophic muscles. Here, we examined whether dominant-negative forms of IKK[alpha] (IKK[alpha]-dn) and IKK[beta] (IKK[beta]-dn) delivered by adeno-associated viral (AAV) vectors to the gastrocnemius (GAS) and tibialis anterior (TA) muscles of 1, 2 and 11-month-old mdx mice, a murine DMD model, block NF-[kappa]B activation and increase muscle regeneration. At 1 month post-treatment, the levels of nuclear NF-[kappa]B in locally treated muscle were decreased by gene transfer with either AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn, but not by IKK wild-type controls (IKK[alpha] and [beta]) or phosphate-buffered saline (PBS). Although treatment with AAV-IKK[alpha]-dn or AAV-IKK[beta]-dn vectors had no significant effect on muscle regeneration in young mdx mice treated at 1 and 2 months of age and collected 1 month later, treatment of old (11 months) mdx with AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn significantly increased levels of muscle regeneration. In addition, there was a significant decrease in myofiber necrosis in the AAV-IKK[alpha]-dn- and AAV-IKK[beta]-dn-treated mdx muscle in both young and old mice. These results demonstrate that inhibition of IKK[alpha] or IKK[beta] in dystrophic muscle reduces the adverse effects of NF-[kappa]B signaling, resulting in a therapeutic effect. Moreover, these results clearly demonstrate the therapeutic benefits of inhibiting NF-[kappa]B activation by AAV gene transfer in dystrophic muscle to promote regeneration, particularly in older mdx mice, and block necrosis. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0969-7128</identifier><identifier>EISSN: 1476-5462</identifier><identifier>DOI: 10.1038/gt.2010.110</identifier><language>eng</language><publisher>Houndmills: Nature Publishing Group</publisher><subject>Gene therapy ; Inflammatory diseases ; Kinases ; Muscular system ; Rodents</subject><ispartof>Gene therapy, 2010-12, Vol.17 (12), p.1476</ispartof><rights>Copyright Nature Publishing Group Dec 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids></links><search><creatorcontrib>Tang, Y</creatorcontrib><creatorcontrib>Reay, D P</creatorcontrib><creatorcontrib>Salay, M N</creatorcontrib><creatorcontrib>Mi, M Y</creatorcontrib><creatorcontrib>Clemens, P R</creatorcontrib><creatorcontrib>Guttridge, D C</creatorcontrib><creatorcontrib>Robbins, P D</creatorcontrib><creatorcontrib>Huard, J</creatorcontrib><creatorcontrib>Wang, B</creatorcontrib><title>Inhibition of the IKK/NF-[kappa]B pathway by AAV gene transfer improves muscle regeneration in older mdx mice</title><title>Gene therapy</title><description>The I[kappa]B kinase (IKK[alpha], [beta] and the regulatory subunit IKK[gamma]) complex regulates nuclear factor of [kappa]B (NF-[kappa]B) transcriptional activity, which is upregulated in many chronic inflammatory diseases. NF-[kappa]B signaling promotes inflammation and limits muscle regeneration in Duchenne muscular dystrophy (DMD), resulting in fibrotic and fatty tissue replacement of muscle that exacerbates the wasting process in dystrophic muscles. Here, we examined whether dominant-negative forms of IKK[alpha] (IKK[alpha]-dn) and IKK[beta] (IKK[beta]-dn) delivered by adeno-associated viral (AAV) vectors to the gastrocnemius (GAS) and tibialis anterior (TA) muscles of 1, 2 and 11-month-old mdx mice, a murine DMD model, block NF-[kappa]B activation and increase muscle regeneration. At 1 month post-treatment, the levels of nuclear NF-[kappa]B in locally treated muscle were decreased by gene transfer with either AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn, but not by IKK wild-type controls (IKK[alpha] and [beta]) or phosphate-buffered saline (PBS). Although treatment with AAV-IKK[alpha]-dn or AAV-IKK[beta]-dn vectors had no significant effect on muscle regeneration in young mdx mice treated at 1 and 2 months of age and collected 1 month later, treatment of old (11 months) mdx with AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn significantly increased levels of muscle regeneration. In addition, there was a significant decrease in myofiber necrosis in the AAV-IKK[alpha]-dn- and AAV-IKK[beta]-dn-treated mdx muscle in both young and old mice. These results demonstrate that inhibition of IKK[alpha] or IKK[beta] in dystrophic muscle reduces the adverse effects of NF-[kappa]B signaling, resulting in a therapeutic effect. Moreover, these results clearly demonstrate the therapeutic benefits of inhibiting NF-[kappa]B activation by AAV gene transfer in dystrophic muscle to promote regeneration, particularly in older mdx mice, and block necrosis. [PUBLICATION ABSTRACT]</description><subject>Gene therapy</subject><subject>Inflammatory diseases</subject><subject>Kinases</subject><subject>Muscular system</subject><subject>Rodents</subject><issn>0969-7128</issn><issn>1476-5462</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNotjk1PwkAYhDdGExE9-Qc23gvvfm-PSAQbiF6IF2PItruFYr_sblX-vUU9TSYzeWYQuiUwIcD0dBcmFE6GwBkaEa5kJLik52gEsYwjRai-RFfeHwCAK01HqErqfZEWoWhq3OQ47B1OVqvp0yJ6fTdta97ucWvC_ssccXrEs9kL3rna4dCZ2ueuw0XVds2n87jqfVY63LlT3plfYDEwSzu0KvuNqyJz1-giN6V3N_86RpvFw2b-GK2fl8l8to7aWIVIUcY501pxI2hsrQbNdSZjIYhSkmSEc-t0akEJBRxya5kQRgkepzRlqWJjdPeHHb599M6H7aHpu3pY3GoihQQtCPsB5gFYLA</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Tang, Y</creator><creator>Reay, D P</creator><creator>Salay, M N</creator><creator>Mi, M Y</creator><creator>Clemens, P R</creator><creator>Guttridge, D C</creator><creator>Robbins, P D</creator><creator>Huard, J</creator><creator>Wang, B</creator><general>Nature Publishing Group</general><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20101201</creationdate><title>Inhibition of the IKK/NF-[kappa]B pathway by AAV gene transfer improves muscle regeneration in older mdx mice</title><author>Tang, Y ; Reay, D P ; Salay, M N ; Mi, M Y ; Clemens, P R ; Guttridge, D C ; Robbins, P D ; Huard, J ; Wang, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p97t-7234438874a529dd80848c695517761c144de8bd0757040fdd355a7549b2b3b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Gene therapy</topic><topic>Inflammatory diseases</topic><topic>Kinases</topic><topic>Muscular system</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Y</creatorcontrib><creatorcontrib>Reay, D P</creatorcontrib><creatorcontrib>Salay, M N</creatorcontrib><creatorcontrib>Mi, M Y</creatorcontrib><creatorcontrib>Clemens, P R</creatorcontrib><creatorcontrib>Guttridge, D C</creatorcontrib><creatorcontrib>Robbins, P D</creatorcontrib><creatorcontrib>Huard, J</creatorcontrib><creatorcontrib>Wang, B</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>Proquest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Y</au><au>Reay, D P</au><au>Salay, M N</au><au>Mi, M Y</au><au>Clemens, P R</au><au>Guttridge, D C</au><au>Robbins, P D</au><au>Huard, J</au><au>Wang, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of the IKK/NF-[kappa]B pathway by AAV gene transfer improves muscle regeneration in older mdx mice</atitle><jtitle>Gene therapy</jtitle><date>2010-12-01</date><risdate>2010</risdate><volume>17</volume><issue>12</issue><spage>1476</spage><pages>1476-</pages><issn>0969-7128</issn><eissn>1476-5462</eissn><abstract>The I[kappa]B kinase (IKK[alpha], [beta] and the regulatory subunit IKK[gamma]) complex regulates nuclear factor of [kappa]B (NF-[kappa]B) transcriptional activity, which is upregulated in many chronic inflammatory diseases. NF-[kappa]B signaling promotes inflammation and limits muscle regeneration in Duchenne muscular dystrophy (DMD), resulting in fibrotic and fatty tissue replacement of muscle that exacerbates the wasting process in dystrophic muscles. Here, we examined whether dominant-negative forms of IKK[alpha] (IKK[alpha]-dn) and IKK[beta] (IKK[beta]-dn) delivered by adeno-associated viral (AAV) vectors to the gastrocnemius (GAS) and tibialis anterior (TA) muscles of 1, 2 and 11-month-old mdx mice, a murine DMD model, block NF-[kappa]B activation and increase muscle regeneration. At 1 month post-treatment, the levels of nuclear NF-[kappa]B in locally treated muscle were decreased by gene transfer with either AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn, but not by IKK wild-type controls (IKK[alpha] and [beta]) or phosphate-buffered saline (PBS). Although treatment with AAV-IKK[alpha]-dn or AAV-IKK[beta]-dn vectors had no significant effect on muscle regeneration in young mdx mice treated at 1 and 2 months of age and collected 1 month later, treatment of old (11 months) mdx with AAV-CMV-IKK[alpha]-dn or AAV-CMV-IKK[beta]-dn significantly increased levels of muscle regeneration. In addition, there was a significant decrease in myofiber necrosis in the AAV-IKK[alpha]-dn- and AAV-IKK[beta]-dn-treated mdx muscle in both young and old mice. These results demonstrate that inhibition of IKK[alpha] or IKK[beta] in dystrophic muscle reduces the adverse effects of NF-[kappa]B signaling, resulting in a therapeutic effect. Moreover, these results clearly demonstrate the therapeutic benefits of inhibiting NF-[kappa]B activation by AAV gene transfer in dystrophic muscle to promote regeneration, particularly in older mdx mice, and block necrosis. [PUBLICATION ABSTRACT]</abstract><cop>Houndmills</cop><pub>Nature Publishing Group</pub><doi>10.1038/gt.2010.110</doi></addata></record>
fulltext fulltext
identifier ISSN: 0969-7128
ispartof Gene therapy, 2010-12, Vol.17 (12), p.1476
issn 0969-7128
1476-5462
language eng
recordid cdi_proquest_journals_816560851
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Gene therapy
Inflammatory diseases
Kinases
Muscular system
Rodents
title Inhibition of the IKK/NF-[kappa]B pathway by AAV gene transfer improves muscle regeneration in older mdx mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T03%3A40%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20the%20IKK/NF-%5Bkappa%5DB%20pathway%20by%20AAV%20gene%20transfer%20improves%20muscle%20regeneration%20in%20older%20mdx%20mice&rft.jtitle=Gene%20therapy&rft.au=Tang,%20Y&rft.date=2010-12-01&rft.volume=17&rft.issue=12&rft.spage=1476&rft.pages=1476-&rft.issn=0969-7128&rft.eissn=1476-5462&rft_id=info:doi/10.1038/gt.2010.110&rft_dat=%3Cproquest%3E2207886421%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=816560851&rft_id=info:pmid/&rfr_iscdi=true